- Home
- HGTY vs AUTL Comparison
HGTY vs AUTL Comparison
Compare HGTY & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGTY
- AUTL
- Stock Information
- Founded
- HGTY 1984
- AUTL 2014
- Country
- HGTY United States
- AUTL United Kingdom
- Employees
- HGTY N/A
- AUTL N/A
- Industry
- HGTY Specialty Insurers
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HGTY Finance
- AUTL Health Care
- Exchange
- HGTY Nasdaq
- AUTL Nasdaq
- Market Cap
- HGTY 938.5M
- AUTL 1.1B
- IPO Year
- HGTY N/A
- AUTL 2018
- Fundamental
- Price
- HGTY $10.66
- AUTL $4.70
- Analyst Decision
- HGTY Hold
- AUTL Strong Buy
- Analyst Count
- HGTY 2
- AUTL 2
- Target Price
- HGTY $11.00
- AUTL $9.50
- AVG Volume (30 Days)
- HGTY 52.2K
- AUTL 715.4K
- Earning Date
- HGTY 11-06-2024
- AUTL 10-31-2024
- Dividend Yield
- HGTY N/A
- AUTL N/A
- EPS Growth
- HGTY N/A
- AUTL N/A
- EPS
- HGTY 0.11
- AUTL N/A
- Revenue
- HGTY $1,105,550,000.00
- AUTL $10,497,000.00
- Revenue This Year
- HGTY $20.27
- AUTL $816.67
- Revenue Next Year
- HGTY $16.13
- AUTL $374.47
- P/E Ratio
- HGTY $99.72
- AUTL N/A
- Revenue Growth
- HGTY 23.75
- AUTL 40.22
- 52 Week Low
- HGTY $7.52
- AUTL $2.21
- 52 Week High
- HGTY $12.35
- AUTL $7.45
- Technical
- Relative Strength Index (RSI)
- HGTY 46.30
- AUTL 72.40
- Support Level
- HGTY $10.33
- AUTL $3.92
- Resistance Level
- HGTY $10.91
- AUTL $4.38
- Average True Range (ATR)
- HGTY 0.26
- AUTL 0.22
- MACD
- HGTY 0.04
- AUTL 0.09
- Stochastic Oscillator
- HGTY 72.53
- AUTL 88.64
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.